We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
+10.75%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.83%
AUM
$1.14B
AUM Growth
+$47.3M
Cap. Flow
-$93.6M
Cap. Flow %
-8.23%
Top 10 Hldgs %
18.14%
Holding
253
New
32
Increased
64
Reduced
41
Closed
33

Top Sells

Rank Stock Value
1
TMDX icon
Transmedics
TMDX
+$13.7M
2
HALO icon
Halozyme
HALO
+$10.2M
3
CVCO icon
Cavco Industries
CVCO
+$9.29M
4
MTG icon
MGIC Investment
MTG
+$8.12M
5
RRR icon
Red Rock Resorts
RRR
+$6.73M

Sector Composition

Rank Sector Weight
1 Technology 23.1%
2 Industrials 21.35%
3 Healthcare 13.07%
4 Financials 11.12%
5 Consumer Discretionary 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRTX icon
176
Vertex Pharmaceuticals
VRTX
$126B
$490K 0.04%
1,218
-35
-3% -$16.2K
FOUR icon
177
Shift4
FOUR
$3.26B
$468K 0.04%
4,513
PODD icon
178
Insulet
PODD
$9.79B
$458K 0.04%
1,755
TOL icon
179
Toll Brothers
TOL
$14.5B
$454K 0.04%
3,608
-103
-3% -$15.3K
CMG icon
180
Chipotle Mexican Grill
CMG
$41.5B
$411K 0.04%
6,810
TXRH icon
181
Texas Roadhouse
TXRH
$13.7B
$392K 0.03%
2,173
ATSG
182
DELISTED
Air Transport Services Group
ATSG
$370K 0.03%
16,834
-62,584
-79% -$1.24M
SMCI icon
183
Super Micro Computer
SMCI
$20.1B
$336K 0.03%
+11,019
New +$400K
MA icon
184
Mastercard
MA
$493B
$319K 0.03%
+605
New +$313K
V icon
185
Visa
V
$677B
$266K 0.02%
+842
New +$253K
ADBE icon
186
Adobe
ADBE
$105B
-725
Closed -$375K
ALNY icon
187
Alnylam Pharmaceuticals
ALNY
$29.3B
-7,526
Closed -$2.07M
AMD icon
188
Advanced Micro Devices
AMD
$789B
-5,769
Closed -$947K
ARCB icon
189
ArcBest
ARCB
$3.08B
-24,352
Closed -$2.64M
ARHS icon
190
Arhaus
ARHS
$1.36B
-90,672
Closed -$1.12M
ASND icon
191
Ascendis Pharma A/S
ASND
$16.8B
-8,474
Closed -$1.27M
BLBD icon
192
Blue Bird Corp
BLBD
$2.18B
-107,634
Closed -$5.16M
CDNA icon
193
CareDx
CDNA
$2.42B
-164,801
Closed -$5.15M
DKS icon
194
Dick's Sporting Goods
DKS
$18.7B
-17,125
Closed -$3.57M
EL icon
195
Estee Lauder
EL
$32B
-25,073
Closed -$2.5M
GERN icon
196
Geron
GERN
$949M
-494,016
Closed -$2.24M
IBB icon
197
iShares Biotechnology ETF
IBB
$9.71B
-25,939
Closed -$3.78M
IDYA icon
198
IDEAYA Biosciences
IDYA
$3.56B
-29,625
Closed -$939K
IMVT icon
199
Immunovant
IMVT
$8.25B
-33,103
Closed -$944K
KEX icon
200
Kirby Corp
KEX
$6.93B
-43,256
Closed -$5.3M

Similar funds

Nicholas Investment Partners's Q4 2024 Portfolio in Review

As of Q4 2024, Nicholas Investment Partners held 253 positions worth $1.14B, up 4.3% from $1.09B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Nicholas Investment Partners withdrew a net $93.6M in Q4 2024, closing 33 positions and reducing 41 holdings. Its most notable exit was Transmedics, an estimated $13.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Nicholas Investment Partners opened a new position in Rush Street Interactive worth $15M.

  • Nicholas Investment Partners's largest Q4 2024 buy was Rush Street Interactive: 1,091,091 shares worth $15M.
  • Nicholas Investment Partners added most to iShares Russell 2000 ETF in Q4 2024, an estimated $6.59M increase.
  • Nicholas Investment Partners's biggest Q4 2024 reduction was Halozyme, cutting an estimated $10.2M.
  • Nicholas Investment Partners fully exited Transmedics in Q4 2024, selling an estimated $13.7M.
  • Nicholas Investment Partners's ten largest holdings make up 18% of its $1.14B portfolio in Q4 2024.
  • Nicholas Investment Partners opened 32 new positions and closed 33 in Q4 2024.
  • Nicholas Investment Partners's portfolio value rose 4.3% quarter-over-quarter to $1.14B.

Based on Nicholas Investment Partners's 13F filing for Q4 2024, filed 14 Feb 2025.